Two Sigma Investments
RUBY

Two Sigma Investments’s Rubius Therapeutics, Inc RUBY Stock Holding History

Two Sigma Investments’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,200
Closed -$3.36K – 3329
2022
Q4 		$3.36K Buy
+19,200
New +$5.24K ﹤0.01% 2759
2022
Q3 		– Sell
-662,593
Closed -$564K – 2968
2022
Q2 		$564K Buy
662,593
+337,932
+104% +$567K ﹤0.01% 1779
2022
Q1 		$1.79M Buy
324,661
+37,694
+13% +$239K 0.01% 1407
2021
Q4 		$2.78M Buy
286,967
+40,401
+16% +$560K 0.01% 1633
2021
Q3 		$4.41M Buy
246,566
+97,910
+66% +$2.13M 0.01% 1330
2021
Q2 		$3.63M Buy
+148,656
New +$3.72M 0.01% 1405
2021
Q1 		– Sell
-20,755
Closed -$158K – 4362
2020
Q4 		$158K Sell
20,755
-26,336
-56% -$156K ﹤0.01% 3157
2020
Q3 		$236K Sell
47,091
-22,628
-32% -$120K ﹤0.01% 2721
2020
Q2 		$417K Sell
69,719
-19,982
-22% -$118K ﹤0.01% 2139
2020
Q1 		$399K Buy
+89,701
New +$666K ﹤0.01% 2099

Other funds holding RUBY

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

Two Sigma Investments's RUBY Position: Q1 2023 in Review

Two Sigma Investments sold out of Rubius Therapeutics, Inc (RUBY) in Q1 2023, closing a stake of 19,200 shares — an estimated $3.36K sold.

Two Sigma Investments first reported a position in RUBY in Q1 2020 and held it in 10 quarters. The position peaked at $4.41M in Q3 2021. 7 funds tracked by Wall St. Rank hold RUBY as of Q1 2023.

  • Two Sigma Investments reported no remaining Rubius Therapeutics, Inc position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Investments sold 19,200 Rubius Therapeutics, Inc shares in Q1 2023, an estimated $3.36K.
  • Two Sigma Investments first reported a position in Rubius Therapeutics, Inc in Q1 2020 and held it in 10 quarters.
  • Two Sigma Investments's Rubius Therapeutics, Inc position peaked at $4.41M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q1 2023.

Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.